Literature DB >> 29641963

Breakthrough-Therapy Designation - An FDA Perspective.

Jacqueline Corrigan-Curay1, Amy E McKee1, Peter Stein1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29641963     DOI: 10.1056/NEJMc1801222

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Decision Support Tools for Regenerative Medicine: Systematic Review.

Authors:  Ching Lam; Edward Meinert; Abrar Alturkistani; Alison R Carter; Jeffrey Karp; Aidong Yang; David Brindley; Zhanfeng Cui
Journal:  J Med Internet Res       Date:  2018-12-19       Impact factor: 5.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.